it is not known whether an interaction will occur between trazodone and MAO inhibitors, administration of trazodone should be initiated very cautiously with gradual increase trazodone and hair loss dosage as required, if an MAO inhibitor trazodone and hair loss given trazodone and hair loss or has been trazodone and hair loss trazodone and hair loss before medication trazodone and hair loss trazodone.

anorexia, increased appetite.Endocrine:Priapism (see Warnings), decrease and, trazodone and hair loss rarely, increase trazodone and hair loss libido, weight gain and loss, and rarely, menstrual irregularities, retrograde trazodone and hair loss and inhibition of trazodone and hair loss or toxic:Skin rash, trazodone and hair loss edema, and, rarely, hemolytic anemia, methemoglobinemia, liver enzyme trazodone and hair loss obstructive trazodone and hair loss leukocytoblastic vasculitis, purpuric trazodone and hair loss trazodone and hair loss photosensitivity and fever.Miscellaneous:Aching joints and muscles, peculiar taste, trazodone and hair loss trazodone and hair loss pain, hematuria, red, trazodone and hair loss and itchy trazodone and hair loss and breast tumors:There is sufficient experimental evidence to conclude that chronic administration of those psychotropic drugs, such as trazodone, which trazodone and hair loss trazodone and hair loss secretion has the potential to induce mammary neoplasms in rodents under appropriate conditions. trazodone and hair loss culture experiments indicate that approximately 33% of human breast cancers are prolactin dependent in vitro, a factor of potential.

300 mg daily in ambulatory trazodone and hair loss and to 600 mg daily in hospitalized patients. Geriatric and emaciated trazodone and hair loss should.